Best Turnkey Telehealth Platforms for Brand Operators

What should the word platform mean for your business?

Turnkey should describe a deliverable operating arrangement, not merely a collection of software features. A founder needs to know what will be configured, what must be supplied, who provides care and who handles routine administration after launch. A beautiful storefront with unassigned clinical or support work is not a complete operating plan.

Start by writing the first service you intend to sell and the patient journey required to deliver it. Include the independent clinical evaluation, any laboratory step, payment, pharmacy handoff and ongoing support. Then identify the parties responsible for each stage. The telehealth brand-in-a-box guide explains the difference between buying infrastructure and assuming all business responsibilities disappear.

This is an editorial shortlist, not an independently tested performance ranking. Vendor claims are dated as of October 22, 2026. Published launch estimates are useful scoping questions, but they are not interchangeable promises: some start after materials, contracts and approvals are ready, while others describe a narrower technical connection.

Which options are worth evaluating?

When should TEHR be on your shortlist?

TEHR combines white-label technology and administrative infrastructure with an independent licensed clinical network reaching all 50 states, subject to program, state and patient eligibility. Its offering includes clinician e-prescribing, pharmacy coordination, AI-assisted intake, payments and subscriptions. Clinical decisions always remain with independent licensed providers.

TEHR was built by operators behind DudeMeds, Peptiders, TellyMeds and FansMeds who migrated thousands of their own patients. For a turnkey buyer, that experience should translate into practical questions about recurring orders, patient communications and exceptions. Ask the team to map the work it will perform and the inputs your business must provide.

Trade-off: Turnkey does not mean every clinical, medication, laboratory or support cost is included in one software price. TEHR states a flat platform subscription plus flat transaction fee and 0% revenue share; request a scoped quote. Review the platform and operating scope, and note that selected peptide programs are pending and not open for prescribing or fulfillment.

When should you evaluate OpenLoop?

Strength: OpenLoop’s Launchpad describes a no-code website, branded portal, intake, clinicians and operating workflows. The current product is broader than a clinician network; its official page also describes integration into existing customer systems. Official launchpad and platform.

For a turnkey evaluation, ask OpenLoop to demonstrate the proposed storefront-to-fulfillment journey and identify every prerequisite for its launch estimate. Confirm what is built, what is configured and what remains with your team. An existing-stack integration should be compared separately from a complete new-brand implementation.

Trade-off: The reviewed page does not establish a universal numeric rate card or revenue-share policy. Request itemized terms and identify the work your team retains. Treat its fastest launch statement as a vendor estimate with readiness conditions, not a migration guarantee.

When should you evaluate Telegra?

Strength: Telegra describes intake, commerce, pharmacy routing, a branded portal/app and APIs. Its public migration documentation covers CSV imports for patients, products, coupons, orders and subscriptions, with dry-run validation before production import. This is documented import capability, not proof of every outbound export option. Official platform overview; CSV migration.

For a turnkey evaluation, ask Telegra which patient surfaces and operational tools are included in the proposed plan. Separate onboarding from ongoing service charges and confirm the handling of continuing patients. Its documented import tooling is useful, but a complete brand transition also needs clinical and payment continuity.

Trade-off: Request recurring costs separately from published onboarding fees and confirm plan-specific app and pharmacy options. Its conditions page marks peptides Coming Soon; that is not a currently available prescribing or fulfillment program. Conditions and program status.

When should you evaluate Cuvo Health?

Strength: Cuvo’s pricing page publishes platform plans and a completed-consult charge, explicitly states no revenue share or added platform transaction fee, and describes patient/data migration without an additional migration charge. It also distinguishes full-platform plans from its existing-stack Prescribe option. Official pricing.

For a turnkey evaluation, use Cuvo’s published package structure as the beginning of a scope review. Ask what materials, program decisions and commercial arrangements the buyer must supply. Confirm whether the migration offer includes the record types and operating work your existing brand needs, rather than assuming every transition is standard.

Trade-off: Include setup, recurring and clinical charges in the comparison; standard payment-processing and other delivery costs still matter. A clinical connection to an existing stack has different dependencies from building a full brand. Confirm what its migration offer covers for your actual records.

When should you evaluate CareValidate?

Strength: CareValidate describes integrated white-label infrastructure and a nationwide provider network. Its laboratory page outlines both at-home kits and in-person orders, with results connected to charts and provider workflows. Its launch materials describe managed patient support and existing-stack API connectivity. Official provider network; Labs and diagnostics.

For a turnkey evaluation, examine how CareValidate connects support, testing and fulfillment in the proposed program. Ask who follows up when a patient has not completed a required step and how administrative staff escalate a clinical question. The value of a managed arrangement depends on that practical division of work.

Trade-off: Request an itemized fee schedule and migration scope; neither was established on the reviewed public pages. Confirm which support tasks and lab costs are included. A broadly integrated offering still needs a clear handoff when a patient needs clinical rather than administrative help. Launch telehealth.

When should you evaluate Bask Health?

Strength: Bask’s plans page describes storefront, patient portal, EMR/e-prescribing, provider access and pharmacy fulfillment. Its current Core/Growth/Enterprise labels differ from a July 31, 2026 article describing Mini/Growth/Enterprise, so the public packaging should be reconciled before buying. Official plans and pricing; Plan comparison, July 31, 2026.

For a turnkey evaluation, distinguish access to configurable tools from work actually performed for the brand. Ask Bask which setup and recurring administration are included in the current package. Resolve the public plan inconsistency in a written quote before judging either the price or the amount of internal staffing required.

Trade-off: Obtain the current written rate card instead of combining features and prices from conflicting pages. Confirm plan-specific access to integrations and support. Its documented clinical and pharmacy connections mean it should not be described as merely a storefront builder.

When should you evaluate FUSE Health?

Strength: FUSE describes white-label storefront, intake, portal, payments and operational infrastructure with different support levels. Its pricing page labels a percentage-based merchant service fee and contains inconsistent DIY monthly amounts between plan cards and FAQ text. Confirm the current written terms. Official how it works; Pricing.

For a turnkey evaluation, choose the implementation level before comparing the economics. A DIY package and a managed build assign different work to the buyer. Ask FUSE to identify the conditions for launch, confirm current pricing and distinguish its merchant service charge from clinical and other delivery costs.

Trade-off: Model the merchant service fee using the vendor’s terminology, separately from payment processing and clinical costs. Do not recast it as an independently verified revenue-share contract. Decide whether you want self-service configuration or managed implementation before comparing launch packages.

When should you evaluate Wheel?

Strength: Wheel’s Horizon offering combines a configurable platform, clinician network and clinical operations. Its launch page describes an EMR, branded patient experience and modular programs; connected services include prescription fulfillment, pharmacy delivery and laboratory connections. Official launch virtual care; Connected services.

For a turnkey evaluation, match Wheel’s configured care program to the intended channel and patient journey. Confirm the patient experience, connected services and clinical operations that form the package. A complete care program may still require commercial or administrative components from your own organization, so identify those explicitly.

Trade-off: The reviewed public pages do not establish universal numeric pricing or revenue-share terms. Ask how the exact channel, program, patient experience and service connections are packaged. A connection to a service does not necessarily include the cost of using that service.

How should you test the proposed operating model?

Ask each finalist for a launch responsibility schedule. It should list brand assets, domains, entity and contracting work, payment setup, program configuration, required clinical workflows, pharmacy or lab connections, support instructions and patient communications. Each item needs an owner and an acceptance condition.

Then define the launch milestone. A website preview, a tested checkout and a patient completing a clinical journey are different milestones. If the vendor quotes days or weeks, ask which milestone the estimate reaches and what must already be complete before that period begins. Avoid comparing timelines with different starting points.

Run an operational rehearsal before public traffic arrives. Use a patient who needs more information, a failed payment, a pharmacy exception and a support escalation. The platform should make the next action and responsible team clear. This is the practical evidence that a turnkey package is ready to operate rather than merely ready to display.

How should you compare the complete cost?

A turnkey proposal should make the recurring economics understandable as well as the build fee. Separate one-time implementation from platform access, transaction events, clinical services, medication, laboratory work, payment processing, shipping and administrative support. Identify minimums, optional services and charges triggered by exceptions.

Also price the work your own team retains. Content, marketing, customer acquisition and business decisions do not disappear because the backend is supplied. If the package leaves routine administration with the brand, account for that staffing. A package with a lower software fee may or may not cost less to operate.

If your main question is brand control rather than delivery responsibility, read best white label telehealth platforms. The terms overlap, but a branded interface and a managed implementation are different parts of the buying decision.

What changes when you already have patients?

An existing brand needs more than a new-brand launch checklist. Inventory records, consents, active treatments, laboratory results, subscriptions and unresolved cases. Request authorized exports and verify them before committing to a cutover date. Identify which team remains responsible for the next clinical action throughout the transition.

Use the patient migration checklist to separate clinical continuity from commerce migration, then test them together. Payment-token portability requires the appropriate processor procedures; it should not be assumed from a successful CSV import. A turnkey migration plan should name these dependencies rather than compressing them into a generic promise to move patients quickly.

What should happen before the final selection?

Reduce the shortlist to proposals that meet the intended clinical and operating requirements. Record unanswered questions and require scope-specific responses before comparing final economics. Use the resource library for additional definitions and checklists, and the white-label guide to clarify ambiguous terms. The final choice should rest on the operation you can actually run, the responsibilities you understand and the patient journey you have tested.

What else should you know?